LESCOL Drug Patent Profile
✉ Email this page to a colleague
When do Lescol patents expire, and when can generic versions of Lescol launch?
Lescol is a drug marketed by Novartis and Sandoz and is included in two NDAs.
The generic ingredient in LESCOL is fluvastatin sodium. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the fluvastatin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lescol
A generic version of LESCOL was approved as fluvastatin sodium by MYLAN PHARMS INC on April 11th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LESCOL?
- What are the global sales for LESCOL?
- What is Average Wholesale Price for LESCOL?
Summary for LESCOL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Clinical Trials: | 11 |
Patent Applications: | 4,864 |
Drug Prices: | Drug price information for LESCOL |
What excipients (inactive ingredients) are in LESCOL? | LESCOL excipients list |
DailyMed Link: | LESCOL at DailyMed |
Recent Clinical Trials for LESCOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Amgen | Phase 4 |
Brigham and Women's Hospital | Phase 4 |
University of California, San Francisco | Phase 4 |
Paragraph IV (Patent) Challenges for LESCOL
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LESCOL | Capsules | fluvastatin sodium | 20 mg and 40 mg | 020261 | 1 | 2008-06-04 |
US Patents and Regulatory Information for LESCOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | LESCOL | fluvastatin sodium | CAPSULE;ORAL | 020261-001 | Dec 31, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Novartis | LESCOL | fluvastatin sodium | CAPSULE;ORAL | 020261-002 | Dec 31, 1993 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sandoz | LESCOL XL | fluvastatin sodium | TABLET, EXTENDED RELEASE;ORAL | 021192-001 | Oct 6, 2000 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LESCOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | LESCOL | fluvastatin sodium | CAPSULE;ORAL | 020261-002 | Dec 31, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | LESCOL | fluvastatin sodium | CAPSULE;ORAL | 020261-001 | Dec 31, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | LESCOL | fluvastatin sodium | CAPSULE;ORAL | 020261-002 | Dec 31, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | LESCOL | fluvastatin sodium | CAPSULE;ORAL | 020261-001 | Dec 31, 1993 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LESCOL
See the table below for patents covering LESCOL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Israel | 104041 | Pharmaceutical compositions comprising an hmg-CoA reductase inhibitor compound and method for their preparation | ⤷ Sign Up |
European Patent Office | 0114027 | ANALOGS OF MEVALOLACTONE AND DERIVATIVES THEREOF, PROCESSES FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS PHARMACEUTICALS | ⤷ Sign Up |
Spain | 527428 | ⤷ Sign Up | |
South Korea | 900009006 | ⤷ Sign Up | |
New Zealand | 206338 | L -(INDOL-2-YL)- B , W -DIHYDROXYALKANOATES AND PHARMACEUTICAL COMPOSITIONS | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for LESCOL
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0114027 | 96C0022 | Belgium | ⤷ Sign Up | PRODUCT NAME: FLUVASTATINE SODIQUE; NAT. REGISTRATION NO/DATE: 151 IS 207 F 4 19960409; FIRST REGISTRATION: GB 0101/0360 19930823 |
0114027 | SPC/GB93/173 | United Kingdom | ⤷ Sign Up | SPC/GB93/173: 20031122, EXPIRES: 20080822 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |